179 related articles for article (PubMed ID: 31817559)
1. A Highly Active Triterpene Derivative Capable |of Biofilm Damage to Control
Krummenauer ME; Lopes W; Garcia AWA; Schrank A; Gnoatto SCB; Kawano DF; Vainstein MH
Biomolecules; 2019 Dec; 9(12):. PubMed ID: 31817559
[No Abstract] [Full Text] [Related]
2. Antimicrobial properties of amine- and guanidine-functionalized derivatives of betulinic, ursolic and oleanolic acids: Synthesis and structure/activity evaluation.
Spivak AY; Khalitova RR; Nedopekina DA; Gubaidullin RR
Steroids; 2020 Feb; 154():108530. PubMed ID: 31678136
[TBL] [Abstract][Full Text] [Related]
3. Antifungal activity of promethazine and chlorpromazine against planktonic cells and biofilms of Cryptococcus neoformans/Cryptococcus gattii complex species.
Brilhante RSN; Gotay WJP; Pereira VS; de Oliveira JS; Pereira-Neto WA; Castelo-Branco DSCM; Cordeiro RA; Sidrim JJC; Rocha MFG
Med Mycol; 2020 Oct; 58(7):906-912. PubMed ID: 32016364
[TBL] [Abstract][Full Text] [Related]
4. Antifolates inhibit Cryptococcus biofilms and enhance susceptibility of planktonic cells to amphotericin B.
de Aguiar Cordeiro R; Mourão CI; Rocha MF; de Farias Marques FJ; Teixeira CE; de Oliveira Miranda DF; Neto LV; Brilhante RS; de Jesus Pinheiro Gomes Bandeira T; Sidrim JJ
Eur J Clin Microbiol Infect Dis; 2013 Apr; 32(4):557-64. PubMed ID: 23192488
[TBL] [Abstract][Full Text] [Related]
5. Antifungal Activity, Antibiofilm and Association Studies with O-Alkylamidoximes against Cryptococcus spp.
de Castro Teixeira AP; Fernandes Queiroga Moraes G; de Oliveira RJ; Silva Santos C; Alves Caiana RR; Rufino de Freitas JC; Vasconcelos U; de Oliveira Pereira F; Oliveira Lima I
Chem Biodivers; 2023 Mar; 20(3):e202200539. PubMed ID: 36730650
[TBL] [Abstract][Full Text] [Related]
6. Adaptation to Fluconazole via Aneuploidy Enables Cross-Adaptation to Amphotericin B and Flucytosine in Cryptococcus neoformans.
Yang F; Gritsenko V; Lu H; Zhen C; Gao L; Berman J; Jiang YY
Microbiol Spectr; 2021 Oct; 9(2):e0072321. PubMed ID: 34585947
[TBL] [Abstract][Full Text] [Related]
7. Anti-Cryptococcal activity of a furanone derivative-antibiofilm and opsonophagocytic potential.
Rathore SS; Raman T; Lalitha C; Ramar M; Munusamy A; Ramakrishnan J
J Mycol Med; 2020 Jun; 30(2):100924. PubMed ID: 32037102
[TBL] [Abstract][Full Text] [Related]
8. The Antimicrobial Peptide MK58911-NH
Singulani JL; Oliveira LT; Ramos MD; Fregonezi NF; Gomes PC; Galeane MC; Palma MS; Fusco Almeida AM; Mendes Giannini MJS
Antimicrob Agents Chemother; 2021 Nov; 65(12):e0090421. PubMed ID: 34516241
[TBL] [Abstract][Full Text] [Related]
9. Biofilm Formation by Cryptococcus neoformans.
Martinez LR; Casadevall A
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185073
[TBL] [Abstract][Full Text] [Related]
10. Molecular typing and in vitro resistance of Cryptococcus neoformans clinical isolates obtained in Germany between 2011 and 2017.
Selb R; Fuchs V; Graf B; Hamprecht A; Hogardt M; Sedlacek L; Schwarz R; Idelevich EA; Becker SL; Held J; Küpper-Tetzel CP; McCormick-Smith I; Heckmann D; Gerkrath J; Han CO; Wilmes D; Rickerts V
Int J Med Microbiol; 2019 Sep; 309(6):151336. PubMed ID: 31444102
[TBL] [Abstract][Full Text] [Related]
11. Temperature affects the susceptibility of Cryptococcus neoformans biofilms to antifungal agents.
Pettit RK; Repp KK; Hazen KC
Med Mycol; 2010 Mar; 48(2):421-6. PubMed ID: 19637092
[TBL] [Abstract][Full Text] [Related]
12. Darunavir inhibits
Brilhante RSN; Silva JAT; Araújo GDS; Pereira VS; Gotay WJP; Oliveira JS; Guedes GMM; Pereira-Neto WA; Castelo-Branco DSCM; Cordeiro RA; Sidrim JJC; Rocha MFG
J Med Microbiol; 2020 Jun; 69(6):830-837. PubMed ID: 32459616
[No Abstract] [Full Text] [Related]
13. Antifungal susceptibility testing with YeastONE™ is not predictive of clinical outcomes of Cryptococcus neoformans var. grubii fungemia.
Yang JH; Huang PY; Cheng CW; Shie SS; Lin ZF; Yang LY; Lee CH; Wu TS
Med Mycol; 2021 Nov; 59(11):1114-1121. PubMed ID: 34374784
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Oral Encochleated Amphotericin B in a Mouse Model of Cryptococcal Meningoencephalitis.
Lu R; Hollingsworth C; Qiu J; Wang A; Hughes E; Xin X; Konrath KM; Elsegeiny W; Park YD; Atakulu L; Craft JC; Tramont EC; Mannino R; Williamson PR
mBio; 2019 May; 10(3):. PubMed ID: 31138748
[No Abstract] [Full Text] [Related]
15. Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro.
Martinez LR; Casadevall A
Antimicrob Agents Chemother; 2006 Mar; 50(3):1021-33. PubMed ID: 16495265
[TBL] [Abstract][Full Text] [Related]
16. Insights into betulinic acid as a promising molecule to fight the interkingdom biofilm Staphylococcus aureus-Candida albicans.
Hamion G; Aucher W; Mercier A; Tewes F; Menard M; Bertaux J; Girardot M; Imbert C
Int J Antimicrob Agents; 2024 Jun; 63(6):107166. PubMed ID: 38570017
[TBL] [Abstract][Full Text] [Related]
17. In vitro antifungal and antibiofilm activities of halogenated quinoline analogues against Candida albicans and Cryptococcus neoformans.
Zuo R; Garrison AT; Basak A; Zhang P; Huigens RW; Ding Y
Int J Antimicrob Agents; 2016 Aug; 48(2):208-11. PubMed ID: 27256584
[TBL] [Abstract][Full Text] [Related]
18. Unraveling Caspofungin Resistance in Cryptococcus neoformans.
Papon N; Goldman GH
mBio; 2021 Mar; 12(2):. PubMed ID: 33727346
[No Abstract] [Full Text] [Related]
19. In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia.
Trpković A; Pekmezović M; Barać A; Crnčević Radović L; Arsić Arsenijević V
J Mycol Med; 2012 Sep; 22(3):243-8. PubMed ID: 23518082
[TBL] [Abstract][Full Text] [Related]
20. Anthraquinones against
Araújo GDS; Brilhante RSN; Rocha MGD; Aguiar L; Castelo-Branco DSCM; Guedes GMM; Sidrim JJC; Pereira Neto WA; Rocha MFG
J Med Microbiol; 2024 Mar; 73(3):. PubMed ID: 38530134
[No Abstract] [Full Text] [Related]
[Next] [New Search]
